An engineered glutamic acid tRNA for efficient suppression of pathogenic nonsense mutations
Nucleic Acids Research · 20.06.2025 · 53 (12)
DOI: 10.1093/nar/gkaf532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 20.06.2025. Verfasst von Caitlin Specht und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, United States. Hauptthemen laut MEDLINE: Codon, Nonsense, RNA, Transfer, Glutamic Acid. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIGMS NIH HHS, NCATS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Nonsense mutations that introduce premature termination codons (PTCs) into protein-coding genes are responsible for numerous genetic diseases; however, there are currently no effective treatment options for individuals affected by these mutations. One approach to combat nonsense-related diseases relies on the use of engineered suppressor transfer RNAs (sup-tRNAs) that facilitate translational stop codon readthrough, thereby restoring full-length protein synthesis. While several sup-tRNAs have shown promising results in preclinical models, many exhibit low PTC suppression efficiency, precluding their use as therapeutics. For example, glutamic acid (Glu) codons represent one of the most common sites for nonsense mutations, yet existing sup-tRNAs are ineffective at suppressing Glu-to-Stop mutations. To address this limitation, here we describe a rationally designed sup-tRNA (tRNAGluV13) with greatly improved ability to suppress PTCs occurring at Glu codons. We demonstrate that tRNAGluV13 efficiently restores protein synthesis from multiple nonsense-containing reporter genes, faithfully installing Glu in response to PTCs. Additionally, we demonstrate that tRNAGluV13 can functionally rescue pathogenic PTCs that cause hereditary breast and ovarian cancer syndrome and cystic fibrosis. The ability of tRNAGluV13 to effectively suppress one of the most common PTC mutations should greatly expand the potential of sup-tRNA-based therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
- Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
- Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
- Department of Molecular Biology and Biophysics, University of Connecticut School of Medicine, Farmington, CT 06030, United States.
- Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, CT 06032, United States.
- Center for Proteome Analysis, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
ORCID-Profile: Emma H Doud, Oscar Vargas-Rodriguez, Jeffery M Tharp
Förderung
- NIGMS NIH HHS
- NCATS NIH HHS
- NCI NIH HHS
- Cystic Fibrosis Foundation
- Indiana University School of Medicine
- IU Simon Comprehensive Cancer Center
- Indiana Clinical and Translational Sciences Institute
- National Center for Advancing Translational Sciences
Zitieren
APA
Specht, C., Tapia, A., Penrod, S., Soriano, G. A., Awawdeh, A., Alshawi, S. A., White, C. A., Beaudoin, J. D., Doud, E. H., Vargas-Rodriguez, O., Huang, Y., & Tharp, J. M. (2025). An engineered glutamic acid tRNA for efficient suppression of pathogenic nonsense mutations. Nucleic Acids Research, 53(12). https://doi.org/10.1093/nar/gkaf532
Vancouver
Specht C, Tapia A, Penrod S, Soriano GA, Awawdeh A, Alshawi SA, et al. An engineered glutamic acid tRNA for efficient suppression of pathogenic nonsense mutations. Nucleic Acids Research. 2025;53(12). doi:10.1093/nar/gkaf532
BibTeX
@article{Specht2025,
author = {Specht, Caitlin and Tapia, Alejandro and Penrod, Sarah and Soriano, Gabriela A and Awawdeh, Aya and Alshawi, Sarah A and White, Cody A and Beaudoin, Jean-Denis and Doud, Emma H and Vargas-Rodriguez, Oscar and Huang, Yunjie and Tharp, Jeffery M},
title = {An engineered glutamic acid tRNA for efficient suppression of pathogenic nonsense mutations},
journal = {Nucleic Acids Research},
year = {2025},
volume = {53},
number = {12},
doi = {10.1093/nar/gkaf532}
}
EUVIMED